Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Opinion and Comment
Nature Biotechnology 25, 1084–1087 (1 October 2007) | doi:10.1038/nbt1007-1084
The FDA animal efficacy rule and biodefense
&
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
